関連する実験動画

Updated: Sep 10, 2025

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells

Published on: February 8, 2018

[免疫チェックポイント阻害剤療法における進行後の生存率と全生存率の相関に関するベイジアン回帰モデル]

Motoko Kaneko¹, Toshihiro Shida, Yoshiki Abe

¹Dept. of Pharmacy, Yamagata University Hospital.

Gan to kagaku ryoho. Cancer & chemotherapy

|August 21, 2025

まとめ

進行後の生存 (PPS) は,免疫チェックポイント阻害剤 (ICI) で治療された進行した非小細胞肺がんにおける全生存 (OS) を著しく延長します. PPSは,特にペムブロリズマブでOSの予測精度が高く,進行性のない生存期間 (PFS) 以外の安定したメトリックを提供します.

科学分野:

腫瘍学
免疫療法
バイオ統計学

背景:

進行性生存率 (PFS) と全生存率 (OS) は,がん治療の有効性の標準指標である.
免疫チェックポイント阻害剤 (ICI) は遅延反応を示し,従来の生存メトリックの解釈を複雑にする.
ICI治療におけるPFSとOSの関係については,微妙な評価が必要である.

研究の目的:

アテゾリズマブおよびペムブロリズマブで治療された進行性非小細胞肺がん (NSCLC) の全生存期 (OS) への発症後の生存期 (PPS) の影響を分析する.
ICI治療におけるOSに対するPPSの予測精度を評価する.
ICI 治療の有効性を評価する上で PPS の重要性を強調する.

主な方法:

PFS,OS,PPSのデータのベイジアン統計分析
研究集団:アテゾリズマブまたはペムブロリズマブで治療された進行した非小細胞肺がん患者.
治療グループ間の生存指標の比較分析

主要な成果:

PPSの延長は,アテゾリズマブとペムブロリズマブの両方の延長OSに有意に寄与しました.
PPSは,ペンブロリズマブ群でOSの高い予測精度を示した.
ICIに関連した遅い反応と偽進行は,PFSの評価に影響を与える可能性があります.

結論:

PPSは,NSCLCにおけるICI治療の全生存効果を把握するための重要な指標です.
PPSは安定して予測可能なOSを提供し,ICI治療の文脈では特に価値があります.
非線形モデルに関するさらなる研究は,ICI治療における生存指標の予測力を高める可能性がある.

さらに関連する動画

Predictive Immune Modeling of Solid Tumors

Predictive Immune Modeling of Solid Tumors

Published on: February 25, 2020

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

関連する概念動画

Cancer Survival Analysis

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

Comparing the Survival Analysis of Two or More Groups

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...

Parametric Survival Analysis: Weibull and Exponential Methods

Parametric Survival Analysis: Weibull and Exponential Methods

Parametric survival analysis models survival data by assuming a specific probability distribution for the time until an event occurs. The Weibull and exponential distributions are two of the most commonly used methods in this context, due to their versatility and relatively straightforward application.
Weibull Distribution
The Weibull distribution is a flexible model used in parametric survival analysis. It can handle both increasing and decreasing hazard rates, depending on its shape parameter...

Kaplan-Meier Approach

Kaplan-Meier Approach

The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...

Assumptions of Survival Analysis

Assumptions of Survival Analysis

Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.

Tumor Progression

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...